InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: TopherTink post# 535874

Sunday, 11/20/2022 10:50:40 AM

Sunday, November 20, 2022 10:50:40 AM

Post# of 692993
The sponsors of the DVax-L combo trial including Merck used DVax-L as SOC. Obviously they recognized many years ago that NWBO DVax-L would eventually become SOC therefore if they used current SOC the whole trial would be meaningless and worthless once DVax-L proved out and was established as SOC. Obviously they wanted to be the first to hitch their wagons for Combo therapy to the rising star and heir apparent to SOC. ( In their option from NDA inside look.)
Brilliant!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News